Ancient herbs take on diabetic kidney disease: new trial launches

NCT ID NCT07657351

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study will test whether adding a traditional Chinese herbal formula (DKD-1) to standard care can improve kidney function in people with diabetic kidney disease. Sixty-six adults with type 2 diabetes and moderate-to-severe chronic kidney disease will be randomly assigned to receive either standard care alone or standard care plus the herbal formula for 12 weeks. Researchers will measure changes in kidney function, blood sugar control, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Chinese herbal formula DKD-1 (Astragalus, Salvia, Chinese yam, Poria, Moutan, Schisandra, Smilax)
What this could lead to
If it works, this could point toward a safe herbal supplement that helps protect kidney function in people with diabetic kidney disease.
What could go wrong
This is a very small, early pilot study with only 66 people over 12 weeks. The results may not be strong enough to recommend the treatment, and herbal formulas can vary in quality and purity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • China Medical University Beigang Hospital

    Yunlin, Taiwan, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.